a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms
Industry Biotechnology
A.I.dvisor tells us that SONN and SNBIF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and SNBIF's prices will move in lockstep.
Ticker / NAME | Correlation To SONN | 1D Price Change % | ||
---|---|---|---|---|
SONN | 100% | -4.97% | ||
SNBIF - SONN | 28% Poorly correlated | N/A | ||
NTLA - SONN | 27% Poorly correlated | -1.87% | ||
PRME - SONN | 27% Poorly correlated | -3.00% | ||
CHRS - SONN | 26% Poorly correlated | +0.59% | ||
ABCL - SONN | 26% Poorly correlated | -2.45% | ||
More |